ArticleOpen forum infectious diseases2021

Case Report: Reversal of Integrase Inhibitor- and Tenofovir Alafenamide-Related Weight Gain After Switching Back to Efavirenz/Emtricitabine/Tenofovir DF.

F Will Pohlman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.